The first Design Review date is set for the CVS drugstore project at 4722 Fauntleroy Way SW. We broke the news of the proposal a year and a half ago; after the initial “site plan” filing, it sat dormant for a while. Then back in December, we talked to a CVS rep who said the project was proceeding but not expected to open this year. Now, it’s on the way to Design Review – tentatively set for a March 19th meeting – and the packet just turned up online. Above is the site layout described as the one preferred by the project team (while not labeled as such, the top square labeled “parking” is the Les Schwab lot, not part of the CVS plan). The project now has two numbers and addresses in the city system, one for the building and west parking at 4722 Fauntleroy Way, one for additional parking off the alley, at 4721 38th SW. Here’s the packet currently in the city system (keep in mind, it might be revised before the meeting next month):
The packet put together by architects Schemata Workshop describes the proposal as “a single-story CVS retail building with a pharmacy and a loading mezzanine. The project will include parking and a drive-through for the pharmacy. Loading will be accommodated in the alley.” That’s the alley east of the 4700 block of Fauntleroy, where the drugstore is planned to replace the building that currently houses West Seattle Produce and the consignment store Suite Arrangements. While the site is primarily zoned for development up to 85 feet high, the packet notes that there is a covenant for no building higher than 30 feet. It also notes that the land is being leased, not bought. The Design Review schedule says this project will take up both potential meeting slots on March 19th, starting at 6:30 pm.
SIDE NOTE: If you missed the earlier coverage, the West Seattle plan is part of CVS’s expansion into this state; it has stores open now in Burien and Renton, and others planned in Seattle including Wallingford and lower Queen Anne – some of those designs are shown in the packet you can browse above.
| 59 COMMENTS